BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8668334)

  • 1. Oncogenic potential of a pre-T cell receptor lacking the TCR beta variable domain.
    Jacobs H; Ossendorp F; de Vries E; Ungewiss K; von Boehmer H; Borst J; Berns A
    Oncogene; 1996 May; 12(10):2089-99. PubMed ID: 8668334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD3gamma chain is essential for development of both the TCRalphabeta and TCRgammadelta lineages.
    Haks MC; Krimpenfort P; Borst J; Kruisbeek AM
    EMBO J; 1998 Apr; 17(7):1871-82. PubMed ID: 9524111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 reduces lymphomagenesis in deltaV-TCRbeta transgenic mice.
    Acton D; Jacobs H; Domen J; Berns A
    Oncogene; 1997 May; 14(21):2497-501. PubMed ID: 9191049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of CD3gammaepsilon and CD3deltaepsilon dimer expression during murine T cell development.
    Laird RM; Hayes SM
    Mol Immunol; 2009 Dec; 47(2-3):582-9. PubMed ID: 19819020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during alpha beta thymopoiesis.
    Barndt R; Dai MF; Zhuang Y
    J Immunol; 1999 Sep; 163(6):3331-43. PubMed ID: 10477603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Bcl-2 in alpha beta T cell development in mice deficient in the common cytokine receptor gamma-chain: the requirement for Bcl-2 differs depending on the TCR/MHC affinity.
    Nakajima H; Leonard WJ
    J Immunol; 1999 Jan; 162(2):782-90. PubMed ID: 9916699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of T-cell lymphomas in Emu-IEX-1 mice.
    Zhang Y; Finegold MJ; Porteu F; Kanteti P; Wu MX
    Oncogene; 2003 Oct; 22(44):6845-51. PubMed ID: 14534530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of CD4-CD8- alpha beta TCR+NK1.1+ T lymphocytes: thymic selection by self antigen.
    Schulz RJ; Parkes A; Mizoguchi E; Bhan AK; Koyasu S
    J Immunol; 1996 Nov; 157(10):4379-89. PubMed ID: 8906813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD3 components at the surface of pro-T cells can mediate pre-T cell development in vivo.
    Jacobs H; Vandeputte D; Tolkamp L; de Vries E; Borst J; Berns A
    Eur J Immunol; 1994 Apr; 24(4):934-9. PubMed ID: 8149963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different role for mouse and human CD3delta/epsilon heterodimer in preT cell receptor (preTCR) function: human CD3delta/epsilon heterodimer restores the defective preTCR function in CD3gamma- and CD3gammadelta-deficient mice.
    Pan Q; Brodeur JF; Drbal K; Dave VP
    Mol Immunol; 2006 Apr; 43(11):1741-50. PubMed ID: 16412509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced generation but efficient TCR beta-chain selection of CD4+8+ double-positive thymocytes in mice with compromised CD3 complex signaling.
    Würch A; Biro J; Falk I; Mossmann H; Eichmann K
    J Immunol; 1999 Mar; 162(5):2741-7. PubMed ID: 10072519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prethymic expression of a transgenic TCR beta chain on a precursor of T-cells.
    Lincoln GC; Sheng B; Odebralski J; Lucchetta R; Smith RT
    Cell Immunol; 1997 Oct; 181(1):1-12. PubMed ID: 9344490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell receptor CDR3 loop length repertoire is determined primarily by features of the V(D)J recombination reaction.
    Hughes MM; Yassai M; Sedy JR; Wehrly TD; Huang CY; Kanagawa O; Gorski J; Sleckman BP
    Eur J Immunol; 2003 Jun; 33(6):1568-75. PubMed ID: 12778474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ets-1 transcription factor is required for complete pre-T cell receptor function and allelic exclusion at the T cell receptor beta locus.
    Eyquem S; Chemin K; Fasseu M; Bories JC
    Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15712-7. PubMed ID: 15496469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell development in mice expressing splice variants of the protein tyrosine phosphatase CD45.
    Kozieradzki I; Kündig T; Kishihara K; Ong CJ; Chiu D; Wallace VA; Kawai K; Timms E; Ionescu J; Ohashi P; Marth JD; Mak TW; Penninger JM
    J Immunol; 1997 Apr; 158(7):3130-9. PubMed ID: 9120266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes.
    Chervinsky DS; Lam DH; Melman MP; Gross KW; Aplan PD
    Cancer Res; 2001 Sep; 61(17):6382-7. PubMed ID: 11522630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T lymphocyte development in the absence of CD3 epsilon or CD3 gamma delta epsilon zeta.
    Wang B; Wang N; Whitehurst CE; She J; Chen J; Terhorst C
    J Immunol; 1999 Jan; 162(1):88-94. PubMed ID: 9886373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC-restricted T cell receptor signaling is required for alpha beta TCR replacement of the pre T cell receptor.
    Croxford AL; Akilli-Ozturk O; Rieux-Laucat F; Förster I; Waisman A; Buch T
    Eur J Immunol; 2008 Feb; 38(2):391-9. PubMed ID: 18203137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages.
    Mombaerts P; Clarke AR; Rudnicki MA; Iacomini J; Itohara S; Lafaille JJ; Wang L; Ichikawa Y; Jaenisch R; Hooper ML
    Nature; 1992 Nov; 360(6401):225-31. PubMed ID: 1359428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
    Chen FL; Kung JT
    J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.